Identification of CM1 as a Pathogenic Factor in Inflammatory Diseases and Cancer
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background: CM1 (centrocyte/-blast marker 1) was defined by a mAb against concavabalin-A (ConA) activated PBMC. It is expressed in germinal center of human tonsil and on the surface of activated PBMC as well as cancer cells. Recently,increased productions of pro-inflammatory mediators were detected from activated PBMC by CM1 ligation. Methods:However, there is a limitation to explain the exact role of CM1 on inflammation and its related mechanisms, since the identity of CM1 is still not clarified. In our previous study, we have already confirmed that soluble form of CM1 was produced by Raji. Therefore, we performed Q-TOF analysis after immunoprecipitation of concentrated Raji culture supernatant using anti-CM1 mAbs. Results: As a result, we found that CM1 is identical to enolase-1(ENO1), a glycolytic enzyme,and we confirmed that results by silencing ENO1 using siRNA. It was also confirmed through competition assay between anti-CM1 and anti-ENO1 mAbs. Finally, we investigated the possible role of CM1 in inflammatory response and cancer. The ligation of CM1 on Raji cells with anti-CM1mAbs induces the extensive production of prostaglandin E2(PGE2). In addition, the increased activity of matrix metalloproteinase (MMP)-2/9 was shown in NCI-N87, stomach cancer cell line by CM1 stimulation. Conlusion: CM1 is identical to ENO1 and it might be an important role in the regulation of inflammatory responses.
Abstract
Background: CM1 (centrocyte/-blast marker 1) was defined by a mAb against concavabalin-A (ConA) activated PBMC. It is expressed in germinal center of human tonsil and on the surface of activated PBMC as well as cancer cells. Recently,increased productions of pro-inflammatory mediators were detected from activated PBMC by CM1 ligation. Methods:However, there is a limitation to explain the exact role of CM1 on inflammation and its related mechanisms, since the identity of CM1 is still not clarified. In our previous study, we have already confirmed that soluble form of CM1 was produced by Raji. Therefore, we performed Q-TOF analysis after immunoprecipitation of concentrated Raji culture supernatant using anti-CM1 mAbs. Results: As a result, we found that CM1 is identical to enolase-1(ENO1), a glycolytic enzyme,and we confirmed that results by silencing ENO1 using siRNA. It was also confirmed through competition assay between anti-CM1 and anti-ENO1 mAbs. Finally, we investigated the possible role of CM1 in inflammatory response and cancer. The ligation of CM1 on Raji cells with anti-CM1mAbs induces the extensive production of prostaglandin E2(PGE2). In addition, the increased activity of matrix metalloproteinase (MMP)-2/9 was shown in NCI-N87, stomach cancer cell line by CM1 stimulation. Conlusion: CM1 is identical to ENO1 and it might be an important role in the regulation of inflammatory responses.
참고문헌 (14)
- Hur DY, "CM1, a possible novel activation molecule on human lymphocytes", Immunol Lett, 74, pp.95~102 (2000)
- 강재승, "새로운 종양향원인 CM1을 이용한 종양 진단 ELISA kit의 개발", Immune Network, 5(2), pp.124~129 (2005), 대한면역회
- 이영선, "CM1 Ligation Induces Apoptosis via Fas-FasL Interaction in Ramos Cells, but via Down-regulation of Bcl-2 and Subsequent Decrease of Mitochondrial Membrane Potential in Raji Cells", Immune Network, 6(3), pp.59~66 (2006), 대한면역학회
- Kim D, "CM1 ligation initiates apoptosis in a caspase 8-dependent manner in Ramos cells and in a mitochondria-controlled manner in Raji cells", HUMAN IMMUNOLOGY, 63, pp.576~587 (2002), ELSEVIER SCIENCE INC
- Kim YS, "Ligation of centrocyte", centroblast marker 1 on Epstein-Barr virus--transformed B lymphocytes induces cell death in a reactive oxygen species--dependent manner, 2006, pp.67, 795~807
- Marín JM, "Application of ultra-high-pressure liquid chromatography- tandem mass spectrometry to the determination of multi-class pesticides in environmental and wastewater samples. Study of matrix effects", J Chromatogr A, 1216, pp.1410~1420 (2009)
- Petrovic M, "Multi-residue analysis of pharmaceuticals in wastewater by ultra-performance liquid chromatography-quadrupole-time-of-flight mass spectrometry", J Chromatogr A, 1124, pp.68~81 (2006)
- Pancholi V, "Multifunctional alpha-enolase: its role in diseases", Cell Mol Life Sci, 58, pp.902~920 (2001)
- Giallongo A, "Isolation and partial characterization of a 48-kDa protein which is induced in normal lymphocytes upon mitogenic stimulation", Biochem Biophys Res Commun, 134, pp.1238~1244 (1986)
- Miles LA, "Role of cell-surface lysines in plasminogen binding to cells: identification of alpha-enolase as a candidate plasminogen receptor", Biochemistry, 30, pp.1682~1691 (1991)
- Redlitz A, "The role of an enolase-related molecule in plasminogen binding to cells", Eur J Biochem, 227, pp.407~415 (1995)
- López-Alemany R, "Inhibition of cell surface mediated plasminogen activation by a monoclonal antibody against alpha-Enolase", Am J Hematol, 72, pp.234~242 (2003)
- Pratesi F, "Autoantibodies specific for alpha-enolase in systemic autoimmune disorders", J Rheumatol, 27, pp.109~115 (2000)
- Li J, "The plasminogen activator", plasmin system is essential for development of the joint inflammatory phase of collagen type II-induced arthritis, 2005, pp.166, 783~792